The Wisconsin epidemiologic study of diabetic retinopathy. II Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-6.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2-diabetes: UKPDS 38. UK Prospective Diabetes Study Group
United Kingdom Prospective Diabetes Study Group
United Kingdom Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2-diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Bmj 1998; 317:703-13.
Effect of intensive therapy on the microvascular complications of type 1-diabetes mellitus
Diabetes Control and Complications Trial Group
Diabetes Control and Complications Trial Group: Effect of intensive therapy on the microvascular complications of type 1-diabetes mellitus. Jama 2002; 287: 2563-9.
Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group
Diabetic Retinopathy Study Research Group
Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981; 88: 583-600.
Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19
Early Treatment Diabetic Retinopathy Study Research Group
Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol 1995; 113: 1144-55.
Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema
Gillies MC, Islam FM, Zhu M, Larsson J, Wong TY. Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. Br J Ophthalmol 2007; 91(10): 1323-6.